FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

96214003: Paroxetine hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
201794017 Paroxetine hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
840531013 Paroxetine hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
581000188117 paroxétine chlorhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
831371000172117 chlorhydrate de paroxétine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Paroxetine hydrochloride Is a Serotonin uptake inhibitor false Inferred relationship Some
Paroxetine hydrochloride Is a Product containing paroxetine (medicinal product) false Inferred relationship Some
Paroxetine hydrochloride Is a Serotonin uptake inhibitor false Inferred relationship Some
Paroxetine hydrochloride Is a Paroxetine (substance) false Inferred relationship Some
Paroxetine hydrochloride This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Serotonin reuptake inhibitor (disposition) true Inferred relationship Some
Paroxetine hydrochloride Is a allergène médicamenteux false Inferred relationship Some
Paroxetine hydrochloride Is a Benzodioxole (substance) true Inferred relationship Some
Paroxetine hydrochloride Is a Anxiolytic agent (substance) true Inferred relationship Some
Paroxetine hydrochloride Is a Selective serotonin re-uptake inhibitor true Inferred relationship Some
Paroxetine hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Paroxetine (substance) true Inferred relationship Some
Paroxetine hydrochloride Is a Antidepressant (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely paroxetine 20 milligram/1 each conventional release oral tablet Is a False Paroxetine hydrochloride Inferred relationship Some
Product containing precisely paroxetine 30 milligram/1 each conventional release oral tablet Is a False Paroxetine hydrochloride Inferred relationship Some
Paroxetine 10mg/5mL s/f liquid Is a False Paroxetine hydrochloride Inferred relationship Some
Paroxetine measurement Has measured component (attribute) False Paroxetine hydrochloride Inferred relationship Some
Paroxetine measurement Component True Paroxetine hydrochloride Inferred relationship Some 1
Paroxetine hydrochloride 10mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Paroxetine hydrochloride Inferred relationship Some
Paroxetine hydrochloride 40mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Paroxetine hydrochloride Inferred relationship Some
Paroxetine hydrochloride 20mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Paroxetine hydrochloride Inferred relationship Some
Paroxetine hydrochloride 30mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Paroxetine hydrochloride Inferred relationship Some
Paroxetine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Paroxetine hydrochloride Inferred relationship Some
Paroxetine 25mg tablet controlled-release The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Paroxetine hydrochloride Inferred relationship Some
Paroxetine 12.5mg tablet controlled-release The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Paroxetine hydrochloride Inferred relationship Some
Paroxetine 37.5mg tablet controlled-release The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Paroxetine hydrochloride Inferred relationship Some
Paroxetine 12.5mg gastro-resistant and prolonged-release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Paroxetine hydrochloride Inferred relationship Some
Paroxetine 25mg gastro-resistant and prolonged-release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Paroxetine hydrochloride Inferred relationship Some
Paroxetine 37.5mg gastro-resistant and prolonged-release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Paroxetine hydrochloride Inferred relationship Some
Product containing precisely paroxetine (as paroxetine hydrochloride) 2 milligram/1 milliliter conventional release oral suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paroxetine hydrochloride Inferred relationship Some 1
Product containing precisely paroxetine (as paroxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paroxetine hydrochloride Inferred relationship Some 1
Paroxetine hydrochloride hemihydrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Paroxetine hydrochloride Inferred relationship Some
Product containing precisely paroxetine (as paroxetine hydrochloride) 25 milligram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paroxetine hydrochloride Inferred relationship Some 1
Product containing precisely paroxetine (as paroxetine hydrochloride) 12.5 milligram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paroxetine hydrochloride Inferred relationship Some 1
Product containing precisely paroxetine (as paroxetine hydrochloride) 37.5 milligram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paroxetine hydrochloride Inferred relationship Some 1
Paroxetine hydrochloride anhydrous (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Paroxetine hydrochloride Inferred relationship Some
Product containing precisely paroxetine (as paroxetine hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paroxetine hydrochloride Inferred relationship Some 1
Paroxetine (as paroxetine hydrochloride) 30 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paroxetine hydrochloride Inferred relationship Some 1
Paroxetine (as paroxetine hydrochloride) 40 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paroxetine hydrochloride Inferred relationship Some 1
Paroxetine hydrochloride acetone solvate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Paroxetine hydrochloride Inferred relationship Some

This concept is not in any reference sets

Back to Start